Dong-Hua Luo

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma

Lin-Quan Tang, Chao-Feng Li, Jing Li et al. · JNCI Journal of the National Cancer Institute · 2015 · 386 citations · Full text

Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma

Shu-Biao Ye, Ze-Lei Li, Dong-Hua Luo et al. · Oncotarget · 2014 · 334 citations · Full text

Immunology, Immune Regulation, Extracellular Microvesicles +21

Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial

Qiu-Yan Chen, Yue-Feng Wen, Ling Guo et al. · JNCI Journal of the National Cancer Institute · 2011 · 331 citations · Full text

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

Su-Mei Cao, Qi Yang, Ling Guo et al. · European Journal of Cancer · 2017 · 278 citations

Neoadjuvant Chemotherapy, Radiation Therapy, Medicine +9

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 144 citations

Concurrent Chemoradiotherapy, Nedaplatin Versus Cisplatin, Medicine +10